Investment Thesis
Cardinal Health exhibits concerning financial deterioration with negative stockholders' equity of $2.9B, indicating the company is technically insolvent from an equity perspective. Despite maintaining reasonable operational cash flow of $1.7B, the combination of razor-thin margins (0.7% net margin), declining revenue (-1.9% YoY), and severely strained liquidity ratios (0.91x current ratio) suggests structural operational challenges in the wholesale drug distribution sector. The negative equity position raises substantial questions about long-term sustainability and financial flexibility.
Strengths
- Positive operating cash flow of $1.7B demonstrates ability to generate cash from operations
- Solid free cash flow of $1.4B after capex provides some financial cushion for debt service
- Interest coverage ratio of 8.2x indicates current debt obligations are manageable from an operational standpoint
- Maintains $2.8B in cash reserves providing short-term liquidity buffer
Risks
- Negative stockholders' equity of -$2.9B signals the company is technically insolvent and equity investors have negative book value
- Liquidity crisis indicators: current ratio of 0.91x and quick ratio of 0.44x both below safe thresholds, suggesting potential working capital stress
- Revenue declining 1.9% YoY with extremely thin net margins of 0.7%, leaving minimal operational flexibility or cushion for disruptions
- High long-term debt of $8.3B relative to equity base creates refinancing risk and limits financial flexibility
- Structural profitability challenges with gross margin of only 3.6% in a capital-intensive wholesale distribution business
Key Metrics to Watch
- Stockholders' equity trend - critical to monitor if company can return to positive equity or if losses continue
- Revenue growth stabilization - must reverse negative trend to demonstrate business stability
- Operating cash flow sustainability - any decline would exacerbate liquidity concerns
- Current ratio and working capital position - deterioration would indicate imminent liquidity crisis
- Debt refinancing ability and covenant compliance - given negative equity, lender willingness to extend credit becomes paramount
Financial Metrics
Revenue
129.6B
Net Income
917.0M
EPS (Diluted)
$1.88
Free Cash Flow
1.4B
Total Assets
58.1B
Cash
2.8B
Profitability Ratios
Gross Margin
3.6%
Operating Margin
1.1%
Net Margin
0.7%
ROE
N/A
ROA
1.6%
FCF Margin
1.1%
Balance Sheet & Liquidity
Current Ratio
0.91x
Quick Ratio
0.44x
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
8.18x
Long-term Debt
8.3B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-21T21:16:13.054108 |
Data as of: 2025-12-31 |
Powered by Claude AI